State Street Corporation 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-13 12:10 pm Sale | 2025-03-31 | 13G | Protagonist Therapeutics, Inc. PTGX | STATE STREET CORP STT | 2,706,619 4.400% | -476,923 (-14.98%) | Filing |
| 2024-10-16 12:48 pm Purchase | 2024-09-30 | 13G | Protagonist Therapeutics, Inc. PTGX | STATE STREET CORP STT | 3,183,542 5.400% | 453,613 (+16.62%) | Filing |
| 2024-01-23 10:55 am Sale | 2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | STATE STREET CORP STT | 2,729,929 4.730% | -1,062,997 (-28.03%) | Filing |
| 2023-01-10 08:18 am Sale | 2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | STATE STREET CORP STT | 3,792,926 7.710% | -2,983,343 (-44.03%) | Filing |
| 2022-07-11 11:51 am Purchase | 2022-06-30 | 13G | Protagonist Therapeutics, Inc. PTGX | STATE STREET CORP STT | 6,776,269 13.930% | 4,204,699 (+163.51%) | Filing |
| 2022-02-10 3:41 pm Purchase | 2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | STATE STREET CORP STT | 2,571,570 5.390% | 2,571,570 (New Position) | Filing |